Moreover, Circ-FADS2-mediated miR-498 signaling pathway contributes to lung cancer growth and viabilities, and the patients with low expression level of circFADS2 were considered to have favorable clinical outcomes [50]. Here, FADS2 is linked to lung carcinoma.